Effects of Panax notoginoside on the expression of TGF-β1 and Smad-7 in renal tissues of diabetic rats

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 31, Issue 2, 2011, Pages 190-193

  Tu, Qingnian ^a   Qin, Juan ^a   Dong, Hui ^a   Lu, Fuer ^a   Guan, Wei ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

diabetes; Panax notoginoside; Smad 7; TGF 1

Indexed keywords

HERBACEOUS AGENT; PANAX NOTOGINSENG EXTRACT; SMAD7 PROTEIN; SMAD7 PROTEIN, RAT; TGFB1 PROTEIN, RAT; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; ARTICLE; DIABETIC NEPHROPATHY; EXPERIMENTAL DIABETES MELLITUS; KIDNEY; MALE; METABOLISM; PHYTOTHERAPY; RAT; WISTAR RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUGS, CHINESE HERBAL; KIDNEY; MALE; PHYTOTHERAPY; RATS; RATS, WISTAR; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79957998292     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-011-0250-5     Document Type: Article

References (16)

1. R. Kikkawa M. Togawa M. Isono, et al. 1997 Mechanism of the progression of diabetic nephropathy to renal failure Kidney Int Suppl 62 S39 S40 9350677 1:STN:280:DyaK1c%2FhtFOkuw%3D%3D
2. R. Derynck Y.E. Zhang 2003 Smad-dependent and Smad-independent pathways in TGF-beta family signalling Nature 425 6958 577 584 14534577 10.1038/nature02006 1:CAS:528:DC%2BD3sXnvV2hs7c%3D (Pubitemid 37280136)
3. P. Kavsak R.K. Rasmussen C.G. Causing, et al. 2000 Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF-beta receptor for degradation Mol Cell 6 6 1365 1375 11163210 10.1016/S1097-2765(00)00134-9 1:CAS:528:DC%2BD3MXlvFahug%3D%3D (Pubitemid 32045929)
4. M. Schiffer L.E. Schiffer A. Gupta, et al. 2002 Inhibitory smads and TGF-beta signaling in glomerular cells J Am Soc Nephrol 13 11 2657 2666 12397035 10.1097/01.ASN.0000033276.06451.50 1:CAS:528:DC%2BD38XnvF2ls7k%3D (Pubitemid 35216034)
5. Tu QN, Dong H, Lu FE. Effects of Panax Notoginoside on the nephropathy in rats with type 1 diabetes. Chin J Integr Med, 2011 (in press).
6. Chen WB, Pan XL. Diagnostics (sixth edition). Beijing: People's Medical Publishing House, 2003,379-380
7. A.E. Raptis G. Viberti 2001 Pathogenesis of diabetic nephropathy Exp Clin Endocrinol Diabetes 109 Suppl2 S424 S437 11460589 10.1055/s-2001-18600 1:CAS:528:DC%2BD3MXlslKnsr8%3D (Pubitemid 32577594)
8. S. Dronavalli I. Duka G.L. Bakris 2008 The pathogenesis of diabetic nephropathy Nat Clin Pract Endocrinol Metab 4 8 444 452 18607402 10.1038/ncpendmet0894 1:CAS:528:DC%2BD1cXovVSjt7Y%3D
9. J. Lang H. Cao A. Wei 1998 Comparative study on effect of Panax notoginseng and ticlid in treating early diabetic nephropathy Zhongguo Zhong Xi Yi Jie He Za Zhi (Chinese) 18 12 727 729 1:STN:280:DC%2BD3MvivVCisA%3D%3D
10. Z.H. Chen J. Li J. Liu, et al. 2008 Saponins isolated from the root of Panax notoginseng showed significant anti-diabetic effects in KK-Ay mice Am J Chin Med 36 5 939 951 19051359 10.1142/S0192415X08006363 1:CAS:528: DC%2BD1cXhsVemt7zL
11. M. Guo H. Liu Xw. Chen 2007 The mechanisms of progression of renal interstitial fibrosis and the therapeutic effects of Panax notoginoside Zhongguo Zhong Xi Yi Jie He Shen Bing Za Zhi (Chinese) 8 3 175 178
12. W. Wang V. Koka H.Y. Lan 2005 Transforming growth factor-β and Smad signaling in kidney diseases Nephrology 10 1 48 56 15705182 10.1111/j.1440-1797. 2005.00334.x (Pubitemid 40349406)
13. Y. Okazaki Y. Yamasaki H.A. Uchida, et al. 2007 Enhanced TGF-β/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor Clin and Exper Nephrol 11 1 77 87 10.1007/s10157-006-0456-1 1:CAS:528:DC%2BD2sXltVWgu7c%3D (Pubitemid 46474968)
14. C.E. Hills P.E. Squires 2010 TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy Am J Nephrol 31 1 68 74 19887790 10.1159/000256659 1:CAS:528:DC%2BC3cXksFCjsg%3D%3D
15. N.J. Laping E. Grygielko A. Mathur, et al. 2002 Inhibition of transforming growth factor (TGF)-β1-induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity: SB-431542 Mol Pharmacol 62 1 58 64 12065755 10.1124/mol.62.1.58 1:CAS:528: DC%2BD38Xlt1KqtLc%3D (Pubitemid 34680516)
16. J. Li S.W. Kang J.L. Kim, et al. 2010 Isoliquiritigenin entails blockade of TGF-beta1-Smad signaling for retarding high glucose-induced mesangial matrix accumulation J Agric Food Chem 58 5 3205 32121 20146476 10.1021/jf9040723 1:CAS:528:DC%2BC3cXhslehsL4%3D